May 29, 2007 -- The US Food and Drug Administration (FDA) has has approved a supplemental biologics license application for a liquid fibrin sealant for vascular surgery, and granted 510(k) clearances ...
Omrix Biopharma receives FDA approval for liquid fibrin sealant, Evicel, for use in vascular surgery
Co announces that on May 9, 2007, the FDA approved its supplemental Biologics License Application to market its liquid fibrin sealant, Evicel, in vascular surgery. The co believes that the vascular ...
The FDA has approved the use of Omrix Biopharmaceuticals’ Evicel (human liquid fibrin sealant) for general hemostasis in surgery.Evicel is an aprotinin-free formulation indicated as an adjunct to ...
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on an additional therapeutic indication for the fibrin sealant Evicel (Omrix ...
NEW YORK--(BUSINESS WIRE)--OMRIX Biopharmaceuticals, Inc. (“Omrix” or the “Company”) (NASDAQ: OMRI), a fully-integrated biopharmaceutical company that develops and markets biosurgical and ...
NEW YORK, March 8 (UPI) -- Omrix said Thursday it filed an application with the U.S. Food and Drug Administration seeking an expanded indication for Evicel. The company's supplemental biological ...
The U.S. Food and Drug Administration (FDA) today approved Evicel Fibrin Sealant, a liquid product that when applied topically helps control oozing from small blood vessels during surgical procedures.
Evicel is contraindicated in individuals known to have anaphylactic or severe systemic reaction to human blood products. As with all plasma-derived products, the risk of transmitting infectious agents ...
Co announces that it has submitted a Supplemental Biologics License Application, or sBLA, to the FDA for approval to market Evicel, the Co's second generation liquid fibrin sealant, with an expanded ...
OMRIX Biopharmaceuticals, Inc. ("OMRIX" or "The Company") (NASDAQ: OMRI), a commercial-stage biopharmaceutical company that develops and markets biosurgical and passive immunotherapy products, ...
WASHINGTON, May 15 (UPI) -- The U.S. Food and Drug Administration has approved Evicel Fibrin Sealant, a liquid coagulant used during surgical procedures. "Evicel provides an effective means to stop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results